REDUcing the burden of dialysis Catheter ComplicaTIOns: a National approach (REDUCCTION)
Healthcare associated infections (HAI) cause significant and life-threatening harm to patients and incur major additional costs. Patients with kidney disease are especially susceptible to HAI, due to the harm associated with central dialysis catheter use. These catheters, essential to the delivery of life-sustaining dialysis treatment, are widely used and are a major driver of bloodstream infection and increased mortality seen in patients receiving dialysis.
The REDUCCTION Partnership Project has the following aims:
- To define the national, clinical and economic burden of dialysis catheter infections in Australia and New Zealand
- To implement an evidence-based and systematic intervention package using a stepped-wedge cluster design with the objective of reducing dialysis catheter-related bacteraemia.
- To establish a framework for monitoring dialysis catheter-related bacteraemia and sustaining improvements from the intervention phase.
Our data collection from 40 ANZ Renal units includes over 3470 participants and 500,000 catheter days. More than 60% of participating sites are now implementing the evidence-based Intervention suite of catheter care, with the final group commencing in March 2019. We are on target to complete site data collection by March 2020.